Back
Warby Parker Vs. Perspective Therapeutics Industry Stock Comparison
Buy
64
WRBY
Warby Parker
Last Price:
21.44
Seasonality Move:
-5.17%
Sell
30
CATX
Perspective Therapeutics
Last Price:
7.88
Seasonality Move:
28.97%
Buy
64
Warby Parker (WRBY)
is a Buy
Is Warby Parker a Buy, Sell or Hold?
- The current Warby Parker [WRBY] share price is $21.34. The Score for WRBY is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- WRBY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $8.92. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
WRBY Stock Price Chart
What is Warby Parker's stock price today?
-
The Warby Parker share price today is $21.34
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and WRBY is experiencing slight buying pressure.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $8.92
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.
WRBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.3 | Buy |
Relative Strength Index (14 RSI): | 79.81 | Buy |
Chaikin Money Flow: | 642564 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (16.16 - 19.6) | Buy |
Bollinger Bands (100): | (14.13 - 17.57) | Buy |
CATX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.71 | Sell |
Relative Strength Index (14 RSI): | 23.03 | Sell |
Chaikin Money Flow: | -1324869 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (10.92 - 12.78) | Sell |
Bollinger Bands (100): | (11.21 - 14.35) | Sell |
WRBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 20.05 | Buy |
20-day SMA: | 18.39 | Buy |
50-day SMA: | 16.47 | Buy |
200-day SMA: | 14.96 | Buy |
8-day EMA: | 20.14 | Buy |
20-day EMA: | 18.7 | Buy |
50-day EMA: | 17.16 | Buy |
200-day EMA: | 15.33 | Buy |
CATX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 11.04 | Sell |
20-day SMA: | 11.63 | Sell |
50-day SMA: | 12.76 | Sell |
200-day SMA: | 12.8 | Sell |
8-day EMA: | 10.64 | Sell |
20-day EMA: | 11.47 | Sell |
50-day EMA: | 12.32 | Sell |
200-day EMA: | 11.71 | Sell |
Warby Parker Earnings Growth & WRBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and an increase next year of $0.08 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.77 per share, and a decrease next year of $0.25 per share.
Warby Parker Technical Analysis
Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Perspective Therapeutics Technical Analysis
Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |